PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal
CONCLUSION: We conclude that this regimen deserves to be preclinically evaluated because of its clinical potential for the treatment of prostate cancer.PMID:37287286 | DOI:10.2174/0929867330666230607104441
Source: Current Medicinal Chemistry - Category: Chemistry Authors: Adriana Romo-Perez Guadalupe Dom ínguez-Gómez Alma Ch ávez-Blanco Aurora Gonz ález-Fierro Jos é Correa-Basurto Alfonso Due ñas-González Source Type: research
More News: Cancer | Cancer & Oncology | Chemistry | Cholesterol | Genetics | Pantoprazole | Prostate Cancer | Protonix | Simvastatin | Statin Therapy | Zocor